W.et al
Patients should also consider time zone changes when scheduling doses and plan to administer injections at consistent intervals relative to their usual schedule
There is limited research on microdosing GLP-1, so the bodys long-term response remains unpredictable and there may be adverse side effects, Zimmermann adds
LIR is suitable to be administered once a day, with a t max of 9~13 hours and t 1/2 of 13 hours ( Compared with the treatment of short-acting GLP-1R agonists, LIR has a greater improvement in lowering glycated hemoglobin and fasting blood glucose
After 52 weeks of treatment, the proportion of participants in the oral semaglutide group achieving an A1C of less than 7.0% was 58.3% (treatment-policy estimand) and 62.8% (trial-product estimand), compared with 25.2% (treatment-policy estimand) and 28.3% (trial-product estimand) for the group receiving 100 mg of sitagliptin daily
These treatments can be effective, but you should consult a healthcare professional to determine the best approach for your needs